繁体中文
设为首页
加入收藏
当前位置:药品说明书与价格首页 >> 呼吸系统病 >> 其他类用药 >> IPD dry syrup 5%(甲磺司特干糖浆)

IPD dry syrup 5%(甲磺司特干糖浆)

2012-10-20 09:16:47  作者:新特药房  来源:中国新特药网天津分站  浏览次数:108  文字大小:【】【】【
简介: 【中文名称】甲磺司特   【别名】(2-(4-(3-乙氧基-2-羟基丙氧基)苯基氨基甲酰)乙基)二甲基锍对甲苯磺酸盐   【英文名称】Suplatast Tosilate   【英文别名】(2-(4-(3-ethoxy-2-hydroxypropoxy)ph ...

英文药名:IPD dry syrup 5%(Suplatast Tosilate)

中文药名:甲磺司特干糖浆

生产厂家:大鹏药业

アイピーディドライシロップ5%

治疗类别名称
过敏性疾病治疗药物
批准上市日期:2001年9月
商標名
IPD dry syrup 5%
構造式

一般名
スプラタストトシル酸塩(Suplatast Tosilate)
化学名
(RS)-[2-[4-(3-Ethoxy-2-hydroxypropoxy)phenylcarbamoyl]ethyl]dimethylsulfonium p-toluenesulfonate
分子式
C16H26NO4S・C7H7O3S
分子量
499.64
融点
82~86℃
性状
白色结晶粉末,或没有异味,或者有轻微异味。非常易溶于水或甲醇,易溶于乙醇(99.5),并在乙醚中几乎不溶。水溶液(1→10)示出了没有旋光性。它是一个潮解.
药效药理
1. 抗过敏作用
(1) 气道高反应的抑制作用
由少年和成熟豚鼠的抗原吸入暴露气道高反应以剂量依赖的方式(1-300毫克/公斤/天[效力比※:1.7-50])。
(2) 实验性哮喘的抑制作用
在被动致敏豚鼠和抑制(10-50mg / kg的实验性哮喘[效力比:.另外,为了抑制在活性致敏小鼠的过敏性气管收缩反应(10-100毫克/千克/天[效力比:1.7至17]),由乙酰甲胆碱(抑制气道高反应10-100毫克/千克/天[效力比:1.1至17])。
(3) 嗜酸性细胞浸润抑制作用
由少年的抗原吸入暴露气道嗜酸性粒细胞浸润和以剂量依赖性成熟豚鼠(1-300毫克/公斤/天[效力比0.2至50])。也有人剂量依赖性由抗原的小鼠腹腔内转移(15-60毫克/公斤)小鼠辅助性T细胞(D10G4.1)嗜酸性粒细胞和腹腔注射渗透抑制。
(4) 白细胞介素产生抑制效果-4(IL-4)和白细胞介素-5(IL-5)
IL-4和IL-5的产生由抗原刺激从D10G4.1中为5μg/ mL或更高抑制,从杉树花粉患者建立辅助T细胞系的IL-4的产量通过1微克/毫升(在抑制体外)。另外,IL-4和IL-5生产的D10G4.1和抗原的情况下,被转移腹膜内到小鼠经腹膜内给药(15-60毫克/公斤)抑制。
(5) IgE抗体产生抑制作用
抑制免疫小鼠(10-100毫克/千克/天[效力比:1.7至17])的IgE抗体产生。应当指出的是,IgM和IgG抗体产生的影响几乎没有观察到。
(6) 化学介质的拮抗作用(体外)
观察到的化学介质如组胺的拮抗作用。
※有效表达剂量的药理试验中的临床每日剂量的情况下,该比例为6毫克/千克/天
2. 作用机序
基于IL-4和从辅助性T细胞的IL-5产生抑制,嗜酸性粒细胞浸润抑制作用,所述的IgE抗体产生抑制作用等的,据信,该抗过敏作用展出。
适应病症
支气管哮喘
用法与用量
见原处方用
包装规格
袋装:
0.75克×56包,1.5克×56包
塑料容器(瓶)为100g,500G


制造厂商
大鹏药业有限公司


完整处方资料附件:http://www.info.pmda.go.jp/go/pack/4490016R1020_1_08/


Brand name : IPD dry syrup 5%(Suplatast tosilate)
Manufacturer's name : TAIHO Pharmaceutical Co.,LTD.
Brand name : IPD dry syrup 5%
Active ingredient: Suplatast tosilate
Dosage form: dry syrup, white 
Printings on wrapping: アイピーディドライシロップ5% 37.5mg/0.75g TC444(0.75g package)
アイピーディドライシロップ5% 75mg/1.5g TC446(1.5g package) 
Effects of this medicine
This drug suppresses allergic reactions by inhibiting T lymphocytes.
It is commonly used to treat bronchial asthma. This medicine is not designed to rapidly alleviate already occurring asthma attacks or symptoms.
Before using this medicine, tell your doctor/pharmacist
If you ever experienced any allergic reaction (itch, rash etc.) to any medicine.
If you are a patient with liver damage.
If you are pregnant or breastfeeding.
If you are using any other prescription or nonprescription (OTC) medicine. (It is important to reduce the risk of drug interactions.)
Dosage regimen (proper use of this medicine)
Your dosage regimen is:(order of your doctor)
General dosage regimen: For children, take 0.06 g per kg of body weight (equivalent to 3mg/kg body weight of suplatast tosilate) twice daily after breakfast and dinner by dissolving the medicine in water just before use. The dose can be decreased or increased according to the patient's age and condition, however daily dosage should not exceed 6 g (300mg) of dry syrup. Strictly follow the instructions of your doctor/pharmacist. If you do not dissolve it, drink the powder with a cup of water.
take the medication as soon as you remember. However, if you remember your medicine at a point close to the time for the next dose, skip one dose and proceed with the prescribed schedule of medication starting from the next dose. DO NOT take a double dose to make up for the missed dose.
Overdose: If you took too much of this medicine (more than ordered), check with your doctor/pharmacist.
Others: Do not stop taking your medicine without the instructions of your doctor.
In the case of children, understanding by parents of the proper use of this medication and parental supervision are needed.
Side effects of this medicine
Common side effects are reported as below. If any of them occurs, check with your doctor/pharmacist:
nose bleeding, stomach discomfort, nausea, sleepiness, rash.
In rare cases, symptoms described below may be the sign of side effects indicated in brackets [ ]. If they occur, stop taking your medicine and check with your doctor immediately.
tiredness, appetite loss, fever, nausea[hepatic dysfunction]
decrease of urinary output, swelling (general), difficult breathing[nephrotic syndrome]
Other side effects not listed here may occur. Check with your doctor/pharmacist if you have any worrisome symptom. 
Storage and other information
Keep out of the reach of babies, infants and children. Avoid direct sunlight and store in a cool dry place.
If you have any left-over medicine, be sure to discard it.

责任编辑:admin


相关文章
克拉霉素小儿用颗粒|CLAROYCIN(Clarithromycin dry syrup 10%)
RHINOJET Inhalation Solution(色甘酸钠吸入溶液)
Zyrtec Dry syrup 1.25%(盐酸西替利嗪干糖浆剂)
Nucala injection(美泊利单抗(基因重组)皮下注射液)
REMICUT CAPSULE(富马酸依美斯汀胶囊)
茶碱糖浆|THEODUR Syrup 2%(Theophylline)
MEDICON Combination Syrup(氢溴酸右美沙芬水合物/钾甲酚磺糖浆)
Pulmicort Respules(布地奈德吸入液)
Dellegra combination tablet(盐酸非索非那定/盐酸伪麻黄碱配合片)
ISOBIDE syrup pack 70%(硝酸异山梨糖浆)
E Keppra Dry syrup 50%(左乙拉西坦干糖浆)
 

最新文章

更多

· 氨茶碱注射剂|Apnission...
· ANSIMAR SCIR. 200 ML 2...
· RINOFLUIMUCIL Mikroneb...
· Fluimucil Grippe Day ...
· Fluimucil 10% Inj(乙酰...
· Fluimucil Gran/Brauset...
· Fluimucil Erkältu...
· RHINOJET Inhalation So...
· MUCOSOLVAN Filmtablett...
· MUCOSOLVAN Brausetable...

推荐文章

更多

· 氨茶碱注射剂|Apnission...
· ANSIMAR SCIR. 200 ML 2...
· RINOFLUIMUCIL Mikroneb...
· Fluimucil Grippe Day ...
· Fluimucil 10% Inj(乙酰...
· Fluimucil Gran/Brauset...
· Fluimucil Erkältu...
· RHINOJET Inhalation So...
· MUCOSOLVAN Filmtablett...
· MUCOSOLVAN Brausetable...

热点文章

更多